About The Book

 

MCI and Alzheimer’s Dementia: Clinical Essentials for Assessment and Treatment of Cognitive-Communication Disorders succinctly presents critical information about the cognitive-communicative disorders associated with mild cognitive impairment (MCI) and Alzheimer’s disease (AD). These are the profession’s fastest-growing clinical populations: a new case of AD is diagnosed every seven seconds.

Notable features of this book include:

  • A focus on Alzheimer’s disease, the most common cause of dementia.
  • Cutting-edge information about MCI, a very early stage of Alzheimer’s disease, and the role of speech-language pathologists (SLPs) in early identification and behavioral and/or pharmacologic treatments.
  • Clinical essentials–definitions, assessments, and treatments–for MCI and AD for students and practicing professionals.

MCI and Alzheimer’s Dementia: Clinical Essentials for Assessment and Treatment of Cognitive-Communication Disorders was written by individuals dedicated to studying the cognitive-communication disorders of dementia and who have developed standardized tests used extensively by SLPs. It is a must-have for clinicians and students who work with patients with MCI or Alzheimer’s disease and is the ideal choice for instructors who teach adult language disorders courses, particularly those that focus on cognitive-communication disorders of adults with dementia.

About The Authors

Kathryn Bayles, PhD is an internationally known expert on the cognitive-communicative disorders of dementia. Now Professor-Emerita at the University of Arizona, Dr. Bayles has served as Department Head of Speech, Language and Hearing Sciences and Associate Director for the National Center for Neurogenic Communication Disorders. Her research has received support from the National Institutes on Aging, Mental Health, Deafness and Other Communication Disorders, the Alzheimer’s Association and the Robert Wood Johnson and Andrus Foundations. She is a Fellow in the American Speech-Language-Hearing Association and Honors recipient and a Past President of the Academy of Neurologic Communication Disorders and Sciences.

Cheryl K. Tomoeda, MS, CCC-SLP is Associate Director of Development for the University of Arizona College of Science after a 22-year career in the Department of Speech, Language, and Hearing Sciences. She is known for her work with Dr. Kathryn Bayles on the communication abilities of individuals with dementia. The two have collaborated on three other books, and co-authored two standardized tests for evaluating the cognitive-communication disorders of dementia, and conducted research on this topic for over 20 years

Table of Contents

Introduction
Definition and discussion of the dementia syndrome and its significance in terms of prevalence and cost.

MCI Defined
Explanation of MCI, its various forms, the recently revised diagnostic criteria established by the NIH and the Alzheimer’s Association, information about rate of conversion to AD, and a review of early changes in language and cognition.

Alzheimer’s Dementia Defined
Diagnostic criteria, neuropathology, risk factors, effects on cognition and communication by stage of disease, and samples of the language of affected individuals by stage of disease.

Assessment of MCI and AD
The process of assessment, reviews of commonly used tests and severity measures, recommendations on tests for screening and comprehensive assessment, and differential diagnosis.

Rationale for intervention
Evidence from cognitive science for the involvement of SLPs in identifying individuals with MCI and AD and treating them directly and indirectly through caregiver counseling to sustain, improve, and/or maximize functioning.

Treatment of MCI
Options SLPs have for helping clients sustain function, including cognitive wellness programs.

Direct Treatment of AD
Treatment guidelines and evidence-based techniques for facilitating learning and information retrieval.

Indirect Treatment of AD
Modifications that SLPs can recommend and oversee regarding the physical and linguistic environment that will enable affected individuals to function at their highest level of ability. Specific recommendations are included about how to communicate with affected individuals and how to improve their ability to comprehend and express language.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Save & Share Cart
Your Shopping Cart will be saved and you'll be given a link. You, or anyone with the link, can use it to retrieve your Cart at any time.
Back Save & Share Cart
Your Shopping Cart will be saved with Product pictures and information, and Cart Totals. Then send it to yourself, or a friend, with a link to retrieve it at any time.
Your cart email sent successfully :)